Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase IIIb, Single-Masked, Multicenter, Randomized Study to Evaluate the Safety and Tolerability of Ranibizumab in Naive and Previously Treated Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
ranibizumab
FVF3689G
NCT00251459
Neovascular Age-related Macular Degeneration
Phase 3
 
December 2015

Powered by ideaPoint, Inc.